Fidelity International’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Fidelity International’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,791	Closed	-$696K	–	926
2021 Q2	$696K	Sell	3,791 -17,884	-83%	-$3.28M	﹤0.01%	767
2021 Q1	$3.31M	Sell	21,675 -52,433	-71%	-$8.02M	﹤0.01%	640
2020 Q4	$11.6M	Sell	74,108 -371,195	-83%	-$58M	0.01%	465
2020 Q3	$51M	Sell	445,303 -78,410	-15%	-$8.97M	0.06%	278
2020 Q2	$58.8M	Sell	523,713 -449,465	-46%	-$50.4M	0.08%	239
2020 Q1	$87.4M	Buy	973,178 +88,728	+10%	+$7.97M	0.14%	161
2019 Q4	$95.7M	Sell	884,450 -319,455	-27%	-$34.5M	0.13%	186
2019 Q3	$118M	Buy	1,203,905 +134,277	+13%	+$13.2M	0.18%	148
2019 Q2	$140M	Sell	1,069,628 -138,939	-11%	-$18.2M	0.21%	128
2019 Q1	$163M	Buy	1,208,567 +1,042,846	+629%	+$141M	0.26%	114
2018 Q4	$16.1M	Buy	165,721 +13,458	+9%	+$1.31M	0.03%	377
2018 Q3	$21.2M	Buy	152,263 +1,681	+1%	+$234K	0.03%	384
2018 Q2	$18.7M	Buy	150,582 +19,618	+15%	+$2.44M	0.03%	406
2018 Q1	$14.6M	Buy	+130,964	New	+$14.6M	0.04%	310
2017 Q3	–	Sell	-71,693	Closed	-$8.72M	–	531
2017 Q2	$8.72M	Hold	71,693	–	–	0.03%	345
2017 Q1	$8.69M	Hold	71,693	–	–	0.02%	359
2016 Q4	$8.77M	Sell	71,693 -3,706	-5%	-$453K	0.03%	344
2016 Q3	$9.24M	Sell	75,399 -29,072	-28%	-$3.56M	0.03%	337
2016 Q2	$12.2M	Sell	104,471 -278,292	-73%	-$32.5M	0.04%	313
2016 Q1	$53.3M	Sell	382,763 -270,782	-41%	-$37.7M	0.17%	132
2015 Q4	$125M	Buy	653,545 +44,434	+7%	+$8.48M	0.38%	72
2015 Q3	$95.3M	Buy	609,111 +88,734	+17%	+$13.9M	0.33%	83
2015 Q2	$94.1M	Buy	520,377 +452,717	+669%	+$81.8M	0.3%	91
2015 Q1	$11.7M	Sell	67,660 -35,180	-34%	-$6.1M	0.04%	345
2014 Q4	$19M	Buy	102,840 +3,551	+4%	+$657K	0.07%	273
2014 Q3	$16.5M	Sell	99,289 -7,374	-7%	-$1.22M	0.06%	271
2014 Q2	$16.7M	Buy	106,663 +2,666	+3%	+$417K	0.06%	288
2014 Q1	$15.8M	Sell	103,997 -20,676	-17%	-$3.15M	0.06%	296
2013 Q4	$16.6M	Buy	+124,673	New	+$16.6M	0.07%	256